Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.

[1]  Ramsay Dh,et al.  Markingink poisoning: an outbreak of methaemoglobin cyanosis in newborn babies. , 1959, Lancet.

[2]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[3]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[4]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[5]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[6]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[7]  P. Steiner,et al.  Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. , 1978, Clinical chemistry.

[8]  S. Shapiro,et al.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Bawol,et al.  Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. , 1980, The New England journal of medicine.

[10]  N. Al-Muhtaseb,et al.  Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction , 1986 .

[11]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[12]  A. Sniderman,et al.  Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. , 1986, The Journal of clinical investigation.

[13]  F. Cambien,et al.  Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. , 1986, American journal of epidemiology.

[14]  F. Labrie,et al.  Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. , 1987, Metabolism: clinical and experimental.

[15]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[16]  I. Holme,et al.  Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. , 1989, American journal of epidemiology.

[17]  G. Dagenais,et al.  First coronary heart disease event rates in relation to major risk factors: Quebec cardiovascular study. , 1990, The Canadian journal of cardiology.

[18]  M. Laakso,et al.  Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. , 1990, Arteriosclerosis.

[19]  S. Grundy,et al.  Does measurement of apolipoprotein B have a place in cholesterol management? , 1990, Arteriosclerosis.

[20]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[21]  S. Eisenberg,et al.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.

[22]  J. Ordovás,et al.  Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. , 1991, Atherosclerosis.

[23]  A. Hamsten,et al.  Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. , 1991, Atherosclerosis.

[24]  Plasma triglyceride and coronary heart disease. , 1991 .

[25]  P. Wilson,et al.  Change in LDL particle size is associated with change in plasma triglyceride concentration. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  A. Gotto.  Hypertriglyceridemia: risks and perspectives. , 1992, The American journal of cardiology.

[27]  P. Björntorp.  Abdominal obesity and the metabolic syndrome. , 1992, Annals of medicine.

[28]  A. Sharrett,et al.  The relation of high density lipoprotein cholesterol and its subfractions to apolipoprotein A-I and fasting triglycerides: the role of environmental factors. The Atherosclerosis Risk in Communities (ARIC) Study. , 1992, American journal of epidemiology.

[29]  Sniderman Ad.  The measurement of apolipoprotein B should replace the conventional lipid profile in screening for cardiovascular risk. , 1992 .

[30]  J. Coresh,et al.  Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease. , 1993, The American journal of cardiology.

[31]  C. Bouchard,et al.  Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[32]  Després Jp.  Abdominal obesity as important component of insulin-resistance syndrome. , 1993, Nutrition.

[33]  S. Eisenberg,et al.  Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[34]  S. Grundy,et al.  Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[35]  R. Krauss,et al.  Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  P. Wilson,et al.  Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. , 1994, Journal of lipid research.

[37]  T. Forte,et al.  The role of apolipoprotein A‐l-containing lipoproteins in atherosclerosis , 1994, Current opinion in lipidology.

[38]  R. Krauss,et al.  Dense low density lipoproteins and coronary artery disease. , 1995, The American journal of cardiology.

[39]  K. Bailey,et al.  The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[40]  G. Dagenais,et al.  Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study) , 1995, The American journal of cardiology.

[41]  J. Després,et al.  The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men , 1996, Diabetes Care.

[42]  C. Bouchard,et al.  Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome. , 1996, Metabolism: clinical and experimental.

[43]  G. Dagenais,et al.  Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study. , 1996, Atherosclerosis.

[44]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.